Suppr超能文献

FcεRI 簇大小决定体外有效肥大细胞脱敏而无效应器反应。

FcεRI Cluster Size Determines Effective Mast Cell Desensitization without Effector Responses in vitro.

机构信息

Laboratory of Hygienic Chemistry, Institute of Medical, Pharmaceutical and Health Sciences, Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan.

出版信息

Int Arch Allergy Immunol. 2022;183(4):453-461. doi: 10.1159/000520132. Epub 2021 Nov 30.

Abstract

BACKGROUND

Allergen-specific desensitization of mast cell (MC) IgE receptors (FcεRI) is an important mechanism of allergen-specific immunotherapy that enables tolerance induction via systemic desensitization. Experimental in vitro IgE-mediated MC desensitization is a potential tool to understand the molecular mechanisms underlying this therapy. Desensitized MCs exhibit internalized IgE and its FcεRI receptors in response to suboptimal doses of allergen without provoking activation. The ovalbumin (OVA) allergen exhibits altered allergenicity upon heat treatment. MC reactions are fundamentally regulated by allergen features (i.e., allergenicity); however, the effects of allergenicity on desensitization remain unclear.

OBJECTIVES

This study aimed to examine the impact of allergenicity on the establishment of in vitro MC desensitization using naive OVA (nOVA) and heated OVA (hOVA), which could induce varying MC effector responses.

METHOD

Bone marrow-derived MCs (BMMCs) were sensitized with OVA-specific IgE, desensitized with sequentially increasing doses of nOVA or hOVA at 10-min intervals, and challenged with nOVA. To evaluate desensitization, the cell surface expression level and subcellular localization of FcεRI-bound IgE were analyzed before and after the final nOVA challenge. MC activation was determined by measuring the release of β-hexosaminidase into supernatants.

RESULTS

Desensitized cells exhibited impaired activation following OVA challenge. Both nOVA and hOVA induced BMMC desensitization under different conditions. Formation of small IgE-FcεRI cluster BMMCs, which adequately represent the desensitized state, was significant. The size of the internalized IgE-FcεRI clusters might be correlated with the desensitized state of MCs.

CONCLUSIONS

We demonstrate that the optimal size of IgE-FcεRI clusters for in vitro BMMC desensitization differed significantly depending on allergenicity, and the efficacy of desensitization was reflected by IgE-FcεRI cluster formation. Our study provides information on the characteristics of IgE-FcεRI internalization for successful desensitization in vitro.

摘要

背景

肥大细胞 (MC) IgE 受体 (FcεRI) 的过敏原特异性脱敏是过敏原特异性免疫治疗的重要机制,通过全身脱敏诱导耐受。实验体外 IgE 介导的 MC 脱敏是理解该治疗机制的潜在工具。脱敏后的 MC 对低剂量过敏原表现出内化的 IgE 及其 FcεRI 受体,而不会引发激活。卵清蛋白 (OVA) 过敏原在热处理后表现出变应原性改变。MC 反应主要受过敏原特性(即变应原性)调节;然而,变应原性对脱敏的影响尚不清楚。

目的

本研究旨在使用幼稚 OVA(nOVA)和加热 OVA(hOVA)检查变应原性对体外 MC 脱敏建立的影响,这两种 OVA 可诱导不同的 MC 效应反应。

方法

用 OVA 特异性 IgE 致敏骨髓来源的 MC(BMMC),用 nOVA 或 hOVA 连续递增剂量在 10 分钟间隔内进行脱敏,然后用 nOVA 进行挑战。为了评估脱敏,在最后一次 nOVA 挑战前后分析 FcεRI 结合的 IgE 的细胞表面表达水平和亚细胞定位。通过测量上清液中β-己糖胺酶的释放来确定 MC 激活。

结果

脱敏细胞在 OVA 挑战后表现出受损的激活。nOVA 和 hOVA 均在不同条件下诱导 BMMC 脱敏。形成小的 IgE-FcεRI 簇 BMMC,充分代表脱敏状态,这是显著的。内化的 IgE-FcεRI 簇的大小可能与 MC 的脱敏状态相关。

结论

我们证明了用于体外 BMMC 脱敏的最佳 IgE-FcεRI 簇大小因变应原性而异,脱敏的功效反映在 IgE-FcεRI 簇的形成上。我们的研究提供了关于成功进行体外脱敏的 IgE-FcεRI 内化特征的信息。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验